Downward dose adjustment of those medications may very well be needed when presented concomitantly with methylphenidate. It may be necessary to change the dosage and check plasma drug concentrations (or, in the case of coumarin, coagulation moments), when initiating or discontinuing concomitant methylphenidate.A drug patent is assigned by the U.S.